Safety, Tolerability, and Pharmacokinetics of Single Doses of BIIB059 in Healthy Japanese Subjects.
Clinical trial NCT03224793 · COMPLETED
Trial details
- NCT number
- NCT03224793
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-04
- Primary completion
- 2018-06-12
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.